The roots of Generali date back to the 1830s and the Bora wind and rough seas that hit the Trieste region... Show more
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Moving Average Convergence Divergence Histogram (MACD) for ARZGF turned negative on July 09, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 29 similar instances when the indicator turned negative. In of the 29 cases the stock turned lower in the days that followed. This puts the odds of success at .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 40, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.698) is normal, around the industry mean (2.112). P/E Ratio (9.911) is within average values for comparable stocks, (16.199). Projected Growth (PEG Ratio) (1.431) is also within normal values, averaging (6.024). Dividend Yield (0.062) settles around the average of (0.054) among similar stocks. P/S Ratio (0.398) is also within normal values, averaging (1.360).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARZGF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry MultiLineInsurance
A.I.dvisor tells us that ARZGF and AEGOF have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARZGF and AEGOF's prices will move in lockstep.
Ticker / NAME | Correlation To ARZGF | 1D Price Change % | ||
---|---|---|---|---|
ARZGF | 100% | N/A | ||
AEGOF - ARZGF | 12% Poorly correlated | N/A | ||
AIVAF - ARZGF | 6% Poorly correlated | N/A | ||
AVVIY - ARZGF | 5% Poorly correlated | N/A | ||
AGESY - ARZGF | 4% Poorly correlated | +1.20% | ||
ARZGY - ARZGF | 4% Poorly correlated | +1.04% | ||
More |